Somatic mutation (SM) analysis provides a useful tool for understanding the stages at which neoplastic differentiate from normal B-cells. B-cell precursor neoplasms are considered to be somatically premutational. However, the variable frequency of SM of the variable region (VH) genes has been described in cases of precursor B-cell acute lymphoblastic leukemia (PB-ALL). To better characterize PB-ALL based on the differentiation stage, we investigated the SM of the VH genes expressed by tumor cells of the surface immunoglobulin (sIg)- HBL-3 cell line derived from childhood PB-ALL. In the HBL-3 cell line, the rearranged Ig heavy chain VH gene sequence showed no SM in the complementarity-determining regions of 1, 2, and 3, or in the framework regions of 1, 2, and 3 relative to the putative germline VH gene sequences. In addition, the VH segment of HBL-3 cells showed no intraclonal sequence heterogeneity, indicating ongoing SM. Our data demonstrated that HBL-3 cells express unmutated and developmentally regulated rearrangement of VH genes at the stage of B-cell precursor cells. HBL-3 cells, which are derived only from the sIg- PB-ALL, showed that SM cannot be recognized in VH genes of tumor cells before the expression of sIg.
BrunningRD, BorowitzM, MatutesE, HeadD, FlandrinG, BennettJM. Precursor B lymphoblastic leukemia/lymphoblastic lymphoma (precursor B-cell acute lymphoblastic leukemia) In: JaffeES, HarrisNL, SteinH, VardimanJW, eds. World Health Organization Classification of Tumors. Pathology & Genetics: Tumors of Hematopoietic and Lymphoid Tumors. Lyon: IARCPress, 2001:111–114.
2.
TonegawaS.Somatic generation of antibody diversity. Nature1983;302:575–581.
3.
MacLennanIC, GrayD.Antigen-driven selection of virgin and memory B cells. Immunol Rev1986;91:61–85.
4.
LiuYJ, JoshuaDE, WilliamsGT, SmithCA, GordonJ, MacLennanIC. Mechanism of antigen-driven selection in germinal centres. Nature1989;342:929–931.
5.
JacobJ, KelsoeG, RajewskyK, WeissU.Intraclonal generation of antibody mutants in germinal centres. Nature1991; 354:389–392.
6.
HentgesF.B lymphocyte ontogeny and immunoglobulin production. Clin Exp Immunol1994;97(Suppl 1):3–9.
7.
KüppersR, KleinU, HansmannML, RajewskyK.Cellular origin of human B-cell lymphomas. N Engl J Med1999;341:1520–1529.
8.
HojoH, SasakiY, NakamuraN, AbeM.Absence of somatic hypermutation of immunoglobulin heavy chain variable region genes in precursor B-lymphoblastic lymphoma: a study of four cases in childhood and adolescence. Am J Clin Pathol2001;116:673–682.
9.
BirdJ, GaliliN, LinkM, StitesD, SklarJ.Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia. J Exp Med1988;168:229–245.
10.
HeightSE, SwansburyGJ, MatutesE, TreleavenJG, CatovskyD, DyerMJS. Analysis of clonal rearrangement of the Ig heavy chain locus in acute leukemia. Blood1996;87:5242–5250.
11.
KitchingmanGR. Immunoglobulin heavy chain gene VH-D junctional diversity at diagnosis in patient with acute lymphoblastic leukemia. Blood1993;81:775–782.
12.
KiyoiH, NaoeT, HoribeK, OhnoR.Characterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells. J Clin Invest1992; 89:739–746.
13.
MaloumK, MagnacC, PritschO, BinetJL, Merle-BeralH, DighieroG.Skewed rearrangement of the VH4-21 gene during pre-B acute lymphoblastic leukemia. Leuk Lymphoma1995;17:435–441.
14.
AbeM, NakamuraN, FukuharaS, A newly established human acute lymphoblastic leukemia cell line with characteristics of the earliest B-cell maturation. Virchows Arch [B]1990;59:107–113.
15.
NozawaY, AbeM, OhnoH, FukuharaS, WakasaH.Production of two monoclonal antibodies (FB1 and FB21) useful for the identification of human B lymphocytes in formalin-fixed, paraffin-embedded tissues. J Pathol1994;173:347–354.
16.
LaiR, MedeirosLJ, WilsonCS, Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf-1, and Ki-67 in multiple myeloma: correlation with cyclin-D1 immunoreactivity. Mod Pathol1998;11:642–647.
17.
MeekerTC, GrimaldiJC, O'RourkeR, LoebJ, JuliussonG, EinhornS.Lack of detectable somatic hypermutation in the V region of the IgH chain gene of a human chronic B lymphocytic leukemia. J Immunol1988;141:3994–3998.
18.
BakkusMH, HeirmanC, Van RietI, Van CampB, ThielemansK.Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood1992;80:2326–2335.
19.
KuzeT, NakamuraN, HashimotoY, AbeM.Most of CD30+ anaplastic large cell lymphoma of B cell type show a somatic mutation in the IgH V region genes. Leukemia1998; 12:753–757.
20.
NakamuraN, HashimotoY, KuzeT, Analysis of the immunoglobulin heavy chain gene variable region of CD5-positive diffuse large B-cell lymphoma. Lab Invest1999;79:925–933.
21.
KüppersR, ZhaoM, HansmannML, RajewskyK.Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J1993;12:4955–4967.
22.
KobrinC, BendandiM, KwakL.Novel secondary Ig VH gene rearrangement and in-frame Ig heavy chain complementarity-determining region III insertion/deletion variants in de novo follicular lymphoma. J Immunol2001;166:2235–2243.
23.
MacLennanIC. Germinal centers. Annu Rev Immunol1994;12:117–139.
24.
RazanajaonaD, DenepouxS, BlanchardD, In vitro triggering of somatic mutation in human naive B cells. J Immunol1997;159:3347–3353.
25.
DenepouxS, RazanajaonaD, BlanchardD, Induction of somatic mutation in a human B cell line in vitro. Immunity1997;6:35–46.
26.
DenepouxS, FournierN, PeronneC, BanchereauJ, LebecqueS.T cells can induce somatic mutation in B cell receptor-engaged BL2 Burkitt's lymphoma cells independently of CD40-CD40 ligand interactions. J Immunol2000; 164:1306–1313.
27.
SaikiRK, GelfandDH, StoffelS, Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science1988;239:487–491.
28.
KoopBF, RowanL, ChenWQ, DeshpandeP, LeeH, HoodL.Sequence length and error analysis of Sequenase and automated Taq cycle sequencing methods. Biotechniques1993;14:442–447.
29.
GabayC, Ben-BassatH, SchlesingerM, LaskovR.Somatic mutations and intraclonal variations in the rearranged Vkappa genes of B-non-Hodgkin's lymphoma cell lines. Eur J Haematol1999;63:180–191.
30.
CoyleLA, PapaioannouM, YaxleyJC, Molecular analysis of the leukaemic B cell in adult and childhood acute lymphoblastic leukaemia. Br J Haematol1996;94:685–693.
31.
LogtenbergT, SchutteME, InghiramiG, Immunoglobulin VH gene expression in human B cell lines and tumors: biased VH gene expression in chronic lymphocytic leukemia. Int Immunol1989;1:362–366.
32.
BermanJE, NickersonKG, PollockRR, VH gene usage in humans: biased usage of the VH6 gene in immature B lymphoid cells. Eur J Immunol1991;21:1311–1314.
33.
DeaneM, NortonJD. Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias. Eur J Immunol1990;20:2209–2217.
34.
MayerR, LogtenbergT, StrauchenJ, CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia. Blood1990;75:1518–1524.
35.
CuisinierAM, GuigouV, BoubliL, FougereauM, TonnelleC.Preferential expression of VH5 and VH6 immunoglobulin genes in early human B-cell ontogeny. Scand J Immunol1989;30:493–497.
